Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening
Catherine M. Albert, Jessica L. Davis, Noah Federman, et al.
Journal of Clinical Oncology (2018) Vol. 37, Iss. 6, pp. 513-524
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

The 2020 WHO Classification
Michael E. Kallen, Jason L. Hornick
The American Journal of Surgical Pathology (2020) Vol. 45, Iss. 1, pp. e1-e23
Closed Access | Times Cited: 252
The genomic landscape of pediatric cancers: Implications for diagnosis and treatment
E. Alejandro Sweet‐Cordero, Jaclyn A. Biegel
Science (2019) Vol. 363, Iss. 6432, pp. 1170-1175
Open Access | Times Cited: 183
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
Ami V. Desai, Giles Robinson, Karen Gauvain, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 10, pp. 1776-1789
Open Access | Times Cited: 74
Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours
David Jones, Ana Banito, Thomas G. P. Grünewald, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 420-438
Closed Access | Times Cited: 130
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target
Alessandro Gambella, Rebecca Senetta, Giammarco Collemi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 753-753
Open Access | Times Cited: 95
A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors
Anna Forsythe, Wei Zhang, U.P. Strauss, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 84
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions
Iva Brčić, Theresa Godschachner, Marko Bergovec, et al.
Modern Pathology (2020) Vol. 34, Iss. 2, pp. 396-407
Open Access | Times Cited: 74
Malignant Peripheral Nerve Sheath Tumors—A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management
Samantha Knight, Tristan Knight, Teresa Santiago, et al.
Children (2022) Vol. 9, Iss. 1, pp. 38-38
Open Access | Times Cited: 41
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C. Benedikt Westphalen, et al.
European Journal of Cancer (2024) Vol. 203, pp. 114046-114046
Open Access | Times Cited: 10
Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer
Noah Federman, Ray McDermott
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 10, pp. 931-939
Open Access | Times Cited: 62
NTRK Fusion-positive Non–small-cell Lung Cancer: The Diagnosis and Targeted Therapy
Naoki Haratake, Takashi Seto
Clinical Lung Cancer (2020) Vol. 22, Iss. 1, pp. 1-5
Open Access | Times Cited: 49
IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors
Mattias K. Andersson, Pierre Åman, Göran Stenman
Cells (2019) Vol. 8, Iss. 8, pp. 913-913
Open Access | Times Cited: 44
A Multistage Transfer Learning Approach for Acute Lymphoblastic Leukemia Classification
Renato R. Maaliw, Alvin Sarraga Alon, Ace C. Lagman, et al.
2022 IEEE 13th Annual Ubiquitous Computing, Electronics & Mobile Communication Conference (UEMCON) (2022)
Closed Access | Times Cited: 26
Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer
Esther Conde, Susana Hernández, Elena Eyre, et al.
Archives of Pathology & Laboratory Medicine (2020) Vol. 145, Iss. 8, pp. 1031-1040
Open Access | Times Cited: 37
Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
Fan Tang, Yan Tie, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188606-188606
Open Access | Times Cited: 32
NTRK fusions and Trk proteins: what are they and how to test for them
Lawrence M. Weiss, Vincent Funari
Human Pathology (2021) Vol. 112, pp. 59-69
Closed Access | Times Cited: 29
Cancer stem cells-driven tumor growth and immune escape: the Janus face of neurotrophins
Viviana Triaca, Valentina Carito, Elena Fico, et al.
Aging (2019) Vol. 11, Iss. 23, pp. 11770-11792
Open Access | Times Cited: 34
NTRK fusions in solid tumours: what every pathologist needs to know
Minh Anh Nguyen, Andrew J. Colebatch, Diana Van Beek, et al.
Pathology (2023) Vol. 55, Iss. 5, pp. 596-609
Open Access | Times Cited: 10
Orientações Práticas sobre a Deteção de Sarcomas de Fusão NTRK: Estado Atual e Desafios Diagnósticos
Isabel Fernandes, Daniela Macedo, Emanuel Gouveia, et al.
Acta Médica Portuguesa (2025) Vol. 38, Iss. 4, pp. 266-275
Open Access
Infantile fibrosarcoma–like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib
Ajay Gupta, Jennifer A. Belsky, Kathleen M. Schieffer, et al.
Molecular Case Studies (2020) Vol. 6, Iss. 5, pp. a005645-a005645
Open Access | Times Cited: 19
Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours
Pilar Garrido, Raquel Hladun, Enrique de Álava, et al.
Clinical & Translational Oncology (2021) Vol. 23, Iss. 8, pp. 1529-1541
Open Access | Times Cited: 18
Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands
Jingjing Sun, Sirui Liu, Kun Fu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 18
New Approaches with Precision Medicine in Adult Brain Tumors
Annette Leibetseder, Matthias Preusser, Anna S. Berghoff
Cancers (2022) Vol. 14, Iss. 3, pp. 712-712
Open Access | Times Cited: 12
NTRK-Fusions – A new kid on the block
Bruno Märkl, Klaus Hirschbühl, Christine Dhillon
Pathology - Research and Practice (2019) Vol. 215, Iss. 10, pp. 152572-152572
Closed Access | Times Cited: 19
Basket trials: From tumour gnostic to tumour agnostic drug development
Christian Dittrich
Cancer Treatment Reviews (2020) Vol. 90, pp. 102082-102082
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top